FISIOLOGÍA Y FARMACOLOGÍA
Departamento
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (8)
2023
-
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
Cells, Vol. 12, Núm. 15
-
Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry
Revista Portuguesa de Cardiologia, Vol. 42, Núm. 3, pp. 237-246
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
2022
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734
2020
-
JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 28, pp. 16492-16499
-
Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy
Revista Espanola de Cardiologia, Vol. 73, Núm. 3, pp. 268-269
2017
-
Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis
Nature Medicine, Vol. 23, Núm. 8, pp. 964-974
2015
-
Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions
Molecular and Cellular Biology, Vol. 35, Núm. 20, pp. 3528-3546